SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,440 | -78.3% | 23,758 | -70.9% | 0.00% | -100.0% |
| Q2 2023 | $379,910 | -79.1% | 81,701 | -79.2% | 0.00% | -75.0% |
| Q1 2023 | $1,818,876 | +13.6% | 393,696 | +98.7% | 0.00% | 0.0% |
| Q4 2022 | $1,600,696 | +50.2% | 198,106 | +3.1% | 0.00% | +33.3% |
| Q3 2022 | $1,066,000 | +245.0% | 192,076 | +223.4% | 0.00% | +200.0% |
| Q2 2022 | $309,000 | +61.8% | 59,397 | +156.3% | 0.00% | – |
| Q1 2022 | $191,000 | -30.3% | 23,176 | +59.6% | 0.00% | -100.0% |
| Q3 2021 | $274,000 | -71.8% | 14,519 | -66.0% | 0.00% | -50.0% |
| Q1 2021 | $971,000 | +197.9% | 42,670 | +184.3% | 0.00% | +100.0% |
| Q4 2020 | $326,000 | – | 15,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |